| Classification criteria for Sjögren’s syndrome C Vitali, N Del Papa Sjögren's Syndrome, 47-60, 2016 | 5366 | 2016 |
| A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease B Iung, G Baron, EG Butchart, F Delahaye, C Gohlke-Bärwolf, OW Levang, ... European heart journal 24 (13), 1231-1243, 2003 | 3712 | 2003 |
| Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration I Boutron, D Moher, DG Altman, KF Schulz, P Ravaud Annals of internal medicine 148 (4), 295-309, 2008 | 2096 | 2008 |
| Guide to clinical trials B Spilker | 1768* | 1992 |
| Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? B Iung, A Cachier, G Baron, D Messika-Zeitoun, F Delahaye, P Tornos, ... European heart journal 26 (24), 2714-2720, 2005 | 1317 | 2005 |
| What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? M Mirabel, B Iung, G Baron, D Messika-Zeitoun, D Détaint, ... European heart journal 28 (11), 1358-1365, 2007 | 807 | 2007 |
| Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement F Tubach, P Ravaud, G Baron, B Falissard, I Logeart, N Bellamy, ... Annals of the rheumatic diseases 64 (1), 29-33, 2005 | 765 | 2005 |
| Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis L Guillevin, C Pagnoux, A Karras, C Khouatra, O Aumaître, P Cohen, ... New England Journal of Medicine 371 (19), 1771-1780, 2014 | 713 | 2014 |
| Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective … F Tubach, D Salmon, P Ravaud, Y Allanore, P Goupille, M Bréban, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 664 | 2009 |
| High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized … JP Fermand, P Ravaud, S Chevret, M Divine, V Leblond, C Belanger, ... Blood, The Journal of the American Society of Hematology 92 (9), 3131-3136, 1998 | 657 | 1998 |
| EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome R Seror, P Ravaud, SJ Bowman, G Baron, A Tzioufas, E Theander, ... Annals of the rheumatic diseases 69 (6), 1103-1109, 2010 | 650 | 2010 |
| Comparison of registered and published primary outcomes in randomized controlled trials S Mathieu, I Boutron, D Moher, DG Altman, P Ravaud Jama 302 (9), 977-984, 2009 | 633 | 2009 |
| Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes I Boutron, S Dutton, P Ravaud, DG Altman Jama 303 (20), 2058-2064, 2010 | 556 | 2010 |
| Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments I Boutron, D Moher, DG Altman, KF Schulz, P Ravaud Annals of internal medicine 148 (4), W-60-W-66, 2008 | 513 | 2008 |
| Infective endocarditis in Europe: lessons from the Euro heart survey P Tornos, B Iung, G Permanyer-Miralda, G Baron, F Delahaye, ... Heart 91 (5), 571-575, 2005 | 486 | 2005 |
| CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts I Boutron, DG Altman, D Moher, KF Schulz, P Ravaud Annals of internal medicine 167 (1), 40-47, 2017 | 456 | 2017 |
| Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS) X Mariette, P Ravaud, S Steinfeld, G Baron, J Goetz, E Hachulla, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 452 | 2004 |
| Quality of life and pharmacoeconomics in clinical trials S McKenna JOURNAL OF COMMUNITY & APPLIED SOCIAL PSYCHOLOGY 7 (5), 425-426, 1997 | 441* | 1997 |
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 426 | 2015 |
| High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized … JP Fermand, S Katsahian, M Divine, V Leblond, F Dreyfus, M Macro, ... Journal of clinical oncology 23 (36), 9227-9233, 2005 | 407 | 2005 |
Xavier MarietteUniversité Paris-Sud, Assistance Publique Hôpitaux de Paris, INSERMVerified email at aphp.fr
